| 000 | 01675 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513112255.0 | ||
| 264 | 0 | _c19970327 | |
| 008 | 199703s 0 0 eng d | ||
| 022 | _a0027-8424 | ||
| 024 | 7 |
_a10.1073/pnas.94.4.1420 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKovacs, M | |
| 245 | 0 | 0 |
_aRecovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. _h[electronic resource] |
| 260 |
_bProceedings of the National Academy of Sciences of the United States of America _cFeb 1997 |
||
| 300 |
_a1420-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBody Weight _xdrug effects |
| 650 | 0 | 4 |
_aCytotoxins _xpharmacology |
| 650 | 0 | 4 |
_aDoxorubicin _xanalogs & derivatives |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xanalogs & derivatives |
| 650 | 0 | 4 |
_aGrowth Hormone _xanalysis |
| 650 | 0 | 4 |
_aLuteinizing Hormone _xanalysis |
| 650 | 0 | 4 |
_aMenstrual Cycle _xdrug effects |
| 650 | 0 | 4 | _aPituitary Function Tests |
| 650 | 0 | 4 |
_aPituitary Gland, Anterior _xdrug effects |
| 650 | 0 | 4 |
_aPyrroles _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aThyrotropin _xanalysis |
| 700 | 1 | _aSchally, A V | |
| 700 | 1 | _aNagy, A | |
| 700 | 1 | _aKoppan, M | |
| 700 | 1 | _aGroot, K | |
| 773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 94 _gno. 4 _gp. 1420-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.94.4.1420 _zAvailable from publisher's website |
| 999 |
_c9025859 _d9025859 |
||